Cargando…

Impella CP use in patients with non‐ischaemic cardiogenic shock

AIMS: From the various mechanical cardiac assist devices and indications available, the use of the percutaneous intraventricular Impella CP pump is usually restricted to acute ischaemic shock or prophylactic indications in high‐risk interventions. In the present study, we investigated clinical usefu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maniuc, Octavian, Salinger, Tim, Anders, Fabian, Müntze, Jonas, Liu, Dan, Hu, Kai, Ertl, Georg, Frantz, Stefan, Nordbeck, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676280/ https://www.ncbi.nlm.nih.gov/pubmed/31095902 http://dx.doi.org/10.1002/ehf2.12446

Ejemplares similares

Value of the CHA(2)DS(2)-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation
por: Liu, Dan, et al.
Publicado: (2018)

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease
por: Liu, Dan, et al.
Publicado: (2018)

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
por: Müntze, Jonas, et al.
Publicado: (2019)

Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis
por: Salinger, Tim, et al.
Publicado: (2018)

Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy
por: Müntze, Jonas, et al.
Publicado: (2018)

Combined Venoarterial ECMO and Impella-CP Circulatory Support for Cardiogenic Shock Due to Papillary Muscle Rupture
por: Ekanem, Emmanuel, et al.
Publicado: (2020)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study
por: Oder, Daniel, et al.
Publicado: (2018)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care
por: Scherer, Clemens, et al.
Publicado: (2020)

Budget Impact Analysis of Impella CP(®) Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis
por: Delmas, Clément, et al.
Publicado: (2022)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

Predictors of Short-term Survival in Cardiogenic Shock Patients Requiring Left Ventricular Support Using the Impella CP or 5.0
por: Panoulas, Vasileios, et al.
Publicado: (2021)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Cardiogenic shock in thyroid storm: A biventricular impella (Bi‐Pella) approach
por: Caruso, Evan, et al.
Publicado: (2021)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022)

Subclinical Aortic Insufficiency Causing Cardiogenic Shock Years After Impella Placement
por: Syed, Ali, et al.
Publicado: (2023)

Use of Impella Devices for Acute Cardiogenic Shock in the Perioperative Period of Cardiac Surgery
por: Sicouri, Serge, et al.
Publicado: (2023)

Successful Treatment of Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction and Acute Mitral Regurgitation by Impella CP
por: Benak, Ales, et al.
Publicado: (2022)

Rationale and Design of JenaMACS—Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock
por: Haertel, Franz, et al.
Publicado: (2022)

Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis
por: Wernly, Bernhard, et al.
Publicado: (2021)

Cardiac amyloidosis mimicking severe aortic valve stenosis – a case report demonstrating diagnostic pitfalls and role of dobutamine stress echocardiography
por: Salinger, Tim, et al.
Publicado: (2017)

Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization
por: Tarantini, Giuseppe, et al.
Publicado: (2021)

Electrical Storm Ablation in a Patient in Cardiogenic Shock Supported by Impella 5.0
por: Le Ruz, Robin, et al.
Publicado: (2021)

Pseudoaneurysm Formation After “Preclose”-Assisted Impella Insertion in a Patient With Cardiogenic Shock
por: Asemota, Daniel, et al.
Publicado: (2022)

Use of Extracorporeal Membrane Oxygenation and Impella as Bridge to Surgery Through Imaging for Cardiogenic Shock
por: Anastasius, Malcolm, et al.
Publicado: (2022)

Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction
por: Saito, Yuichi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lghp7hmh8kidq065diouvak3lg